Previous cytomegalovirus or Chlamydia pneumoniae infection and risk of restenosis after percutaneous transluminal coronary angioplasty

• Published in: The Lancet (British edition) Vol. 350; no. 9086; p. 1225
• Main Authors: Carlsson, Joerg, Miketic, Sinisa, Mueller, Karl-Heinz, Brom, Joachim, Ross, Rolf, von Essen, Rainer, Tebbe, Ulrich
• Format: Journal Article
• Language: English
• Published: London Elsevier Ltd 25.10.1997; Lancet; Elsevier Limited
• Subjects: Angioplasty; Angioplasty, Balloon, Coronary; Biological and medical sciences; Chlamydia Infections - epidemiology; Chlamydophila pneumoniae; Clinical trials; Coronary Artery Disease - epidemiology; Coronary Artery Disease - microbiology; Coronary Artery Disease - therapy; Coronary Disease - epidemiology; Coronary Disease - microbiology; Coronary Disease - therapy; Coronary vessels; Cytomegalovirus Infections - epidemiology; Female; Human viral diseases; Humans; Infections; Infectious diseases; Male; Medical sciences; Middle Aged; Recurrence; Risk Factors; Viral cardiopathies; Viral diseases; Human; Cytomegalovirus; Evaluation; Chlamydia pneumoniae; Chlamydiaceae; Herpesviridae; Cardiovascular disease; Betaherpesvirinae; Coronary heart disease; Percutaneous route; Infection; Vascular disease; Virus; Plasty; Restenosis; Viral disease; Cohort study; Atherosclerosis; Risk factor; Chlamydiales; Bacteria; Complication
• ISSN: 0140-6736; 1474-547X
• DOI: 10.1016/S0140-6736(05)63456-3

A possible association between cytomegalovirus (CMV) infection and restenosis was investigated in a subgroup of patients from the VERAS trial, which was designed to study the effect of octreotide on coronary restenosis after percutaneous transluminal coronary angioplasty.